Feasibility and performance evaluations of Alinity m quantitative NAT for HBV and HCV
Alinity m demonstrated acceptable performance in comparison with Roche Cobas 6800 for HBV and HCV NAT. Additionally, it demonstrated suitability for lower throughput labs in terms of unit test costs.
Authors
- Javeria Aijaz (ORCID: https://orcid.org/0000-0003-4401-4677)
- Zaira Rehman (ORCID: https://orcid.org/0000-0001-9613-4326)
- Fouzia Naseer (ORCID: https://orcid.org/0000-0003-3641-4603)
- Syed Shahmeer Raza (ORCID: https://orcid.org/0000-0002-7125-3334)
- Sana Sajid
Institutions
- Indus Hospital (PK)
Publication Details
- Journal
- Journal of Clinical Virology
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1016/j.jcv.2025.105784
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00